4DMedical (ASX:4DX) said the Mayo Clinic started deploying its CT:VQ cardiothoracic imaging product for ventilation and perfusion analysis, according to a Wednesday Australian bourse filing.
The initial deployment will support clinical workflow integration and build clinician familiarity with the product, with potential to expand to full commercial terms, the filing said.
4DMedical's shares jumped over 31% in recent trading on Wednesday and earlier reached an all-time peak.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.